Glenmede Trust’s Amsurg Corp AMSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-3,005
Closed -$201K 2734
2016
Q3
$201K Buy
3,005
+153
+5% +$10.7K ﹤0.01% 1191
2016
Q2
$220K Sell
2,852
-187
-6% -$14.5K ﹤0.01% 1154
2016
Q1
$226K Sell
3,039
-340
-10% -$23.9K ﹤0.01% 1131
2015
Q4
$256K Sell
3,379
-314,014
-99% -$24.9M ﹤0.01% 1107
2015
Q3
$24.7M Sell
317,393
-135,520
-30% -$10.5M 0.18% 178
2015
Q2
$31.7M Sell
452,913
-157,681
-26% -$10.5M 0.23% 126
2015
Q1
$37.6M Buy
610,594
+4,977
+0.8% +$287K 0.27% 91
2014
Q4
$33.1M Buy
605,617
+104,219
+21% +$5.31M 0.26% 98
2014
Q3
$25.1M Buy
501,398
+143,128
+40% +$7.15M 0.22% 115
2014
Q2
$16.3M Buy
+358,270
New +$16.5M 0.15% 214

Other funds holding AMSG

Glenmede Trust's AMSG Position: Q4 2016 in Review

Glenmede Trust sold out of Amsurg Corp (AMSG) in Q4 2016, closing a stake of 3,005 shares — an estimated $201K sold.

Glenmede Trust first reported a position in AMSG in Q2 2014 and held it in 10 quarters. The position peaked at $37.6M in Q1 2015. 7 funds tracked by Wall St. Rank hold AMSG as of Q4 2016.

  • Glenmede Trust reported no remaining Amsurg Corp position as of Q4 2016 after selling out during the quarter.
  • Glenmede Trust sold 3,005 Amsurg Corp shares in Q4 2016, an estimated $201K.
  • Glenmede Trust first reported a position in Amsurg Corp in Q2 2014 and held it in 10 quarters.
  • Glenmede Trust's Amsurg Corp position peaked at $37.6M in Q1 2015.
  • 7 funds tracked by Wall St. Rank held Amsurg Corp as of Q4 2016.

Based on Glenmede Trust's 13F filing for Q4 2016, filed 14 Feb 2017.